filmov
tv
Recovery trial: lopinavir-ritonavir, Martin Landray
Показать описание
Professor Martin Landray describes how Lopinavir-Ritonavir was investigated as a possible treatment for Covid-19 in the Recovery trial.
Oxford Population Health
Рекомендации по теме
0:00:34
Recovery trial: lopinavir-ritonavir, Martin Landray
0:28:46
Road to RECOVERY: Finding treatments for COVID-19 - Prof Martin Landray
0:00:26
Recovery trial: monoclonal antibodies, Martin Landray
0:12:32
A trial of Lopinavir Ritonavir in Adults Hospitalized with Severe Covid 19
0:00:44
Recovery trial: convalescent plasma, Martin Landray
0:32:45
COVID Conversations: Dexamethasone and the RECOVERY trials
0:45:35
'RECOVERY – reflections and future directions' by Professor Sir Martin Landray
0:06:58
Steroid study that shows reduced Covid-19 deaths: Dr. Martin Landray
0:00:15
Lopinavir Ritonavir only for export
0:00:43
No clinical benefit from use of lopinavir-ritonavir in hospitalized COVID-19 patients!
0:02:00
Ergotismus unter Lopinavir und Ritonavir
0:58:24
RECOVERY trial, one year on
0:03:56
Lopinavir + Ritonavir can reduce the viral load of COVID 19 in a fairly short time
0:00:42
Recovery trial: hydroxychloroquine, Peter Horby
0:00:48
Lopinavir and Ritonavir Medication Overview
0:00:25
Ritonavir Launch
0:00:09
Study finds 4 drugs have little to no effect on COVID-19
0:01:35
WHO discontinues hydroxychloroquine trial for COVID-19 treatment
0:10:59
Assessing Kaletra for COVID-19
0:04:15
Recovery Trial: Dexamethasone in Covid 19
0:36:12
Meet the Doc Who Put Hydroxychloroquine (and More) on Trial in COVID-19
0:00:29
Darunavir - Prezista In a nutshell.
0:31:23
Convalescent plasma, no benefit
0:58:02
COVID 19: KNOWN UNKNOWNS - Interventions
0:00:34
0:28:46
0:00:26
0:12:32
0:00:44
0:32:45
0:45:35
0:06:58
0:00:15
0:00:43
0:02:00
0:58:24
0:03:56
0:00:42
0:00:48
0:00:25
0:00:09
0:01:35
0:10:59
0:04:15
0:36:12
0:00:29
0:31:23
0:58:02